Inhibitory effect of local ischaemic preconditioning in total body irradiated rats.
The aim of this study was to explore the relationship between local ischaemic preconditioning and the effectiveness of fractionated radiotherapy. The rat serum, bone marrow, and small intestine were examined for oxidative changes induced by total body irradiation with gamma rays with applied local ischaemic preconditioning immediately before irradiation. Serum concentrations of TBA-RS examined 12 hours after the last irradiation did not reveal any differences among the groups of animals analyzed. Twenty-four hours after the last dose of irradiation, the serum concentrations of TBA-RS varied in particular groups (P<0.0001). The concentration of triglycerides in the serum of local preconditioned ischaemia and irradiated animals showed a reversed shape similar to the TBA-RS fluctuation (P<0.003). The level of uric acid in the serum of animals treated only with radiation is slightly higher than the level of this acid in the serum of the local preconditioned ischaemia radiation group (P<0.58). The number of bone marrow polychromatic erythrocytes did not appear to differ substantially in both irradiated groups. At the first 12 hours after irradiation, the frequency of micronucleated polychromatic erythrocytes is significantly different in the bone marrow of both groups either in combination with ischaemic preconditioned radiation or with radiation alone (P<0.0002). In irradiated animals without ischaemic preconditioning, on the 3rd day after irradiation the number of crypts increased and in the next days decreased achieving the level of the control group on the 7th day. Irradiated rats with local ischaemic preconditioning did not reveal an increase in the number of crypts. The difference was statistically significant (P<0.05). These data indicate that the local ischaemic preconditioning modifies the radiation peroxidising effects through inhibition of free radical-dependent lipid peroxidation and, probably, other unrecognized mechanisms.
Walichiewicz
Piotr
P
Institute of Oncology, Gliwice, Poland. piotrw@io.gliwice.pl
Przybyszewski
Waldemar M
WM
Jochem
Jerzy
J
Widel
Maria
M
Koterbicka
Aleksandra
A
Snietura
Miroslaw
M
D000818:Animals; D001853:Bone Marrow / Q000528:radiation effects; D019583:Dose Fractionation, Radiation; D004913:Erythrocytes, Abnormal / Q000737:chemistry / Q000378:metabolism / Q000528:radiation effects; D007421:Intestine, Small / Q000528:radiation effects; D019194:Ischemic Preconditioning / Q000379:methods*; D008297:Male; D048629:Micronuclei, Chromosome-Defective / Q000235:genetics / Q000528:radiation effects; D051381:Rats; D017392:Thiobarbituric Acid Reactive Substances / Q000378:metabolism / Q000528:radiation effects; D014280:Triglycerides / Q000097:blood / Q000528:radiation effects; D014527:Uric Acid / Q000097:blood / Q000528:radiation effects; D014916:Whole-Body Irradiation / Q000379:methods*
D017392:Thiobarbituric Acid Reactive Substances; D014280:Triglycerides; D014527:Uric Acid